Applied Therapeutics plunges after UK's Cycle Group to buy co

Applied Therapeutics

12/12/2025 10:22

** Rare diseases drug developer Applied Therapeutics' APLT.O shares slump 35.5% to $0.14 premarket

** Co said on Thursday UK-based Cycle Group will acquire all outstanding shares for $0.088 per share in cash, plus a contingent value right (CVR)

** The offer represents a 60% of discount to APLT's last close of $0.22, though shareholders could receive additional payments (CVR) if specific future milestones are met

** The transaction is expected to close in the first quarter of 2026

** Up to last close, stock down 74.7% YTD

 (Reporting by Utkarsh Tushar Hathi)

 ((utkarshtushar.hathi@thomsonreuters.com))